FDC receives EIR for Aurangabad facility

31 Oct 2018 Evaluate

FDC has received an Establishment Inspection Report (EIR) for its manufacturing facility located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which was inspected from August 10, 2018 to August 16, 2018 by US Food and Drug Administration (USFDA).

The facility is considered to be acceptable with regards to current Good Manufacturing Practices (GMPs) and the inspection stands closed.

FDC is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).

FDC Share Price

410.45 -0.20 (-0.05%)
24-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1737.50
Dr. Reddys Lab 1266.35
Cipla 1496.35
Zydus Lifesciences 917.45
Lupin 2109.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×